Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 30 | 2023 | 69 | 10.060 |
Why?
|
| Endometrium | 9 | 2020 | 57 | 3.720 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 968 | 1.510 |
Why?
|
| Infertility, Female | 3 | 2015 | 24 | 1.030 |
Why?
|
| Chemokine CXCL12 | 2 | 2018 | 28 | 1.020 |
Why?
|
| Quality of Life | 4 | 2020 | 459 | 1.000 |
Why?
|
| Receptors, CXCR4 | 2 | 2018 | 67 | 0.980 |
Why?
|
| Stress, Psychological | 7 | 2020 | 541 | 0.910 |
Why?
|
| Histones | 2 | 2015 | 177 | 0.900 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 859 | 0.880 |
Why?
|
| Female | 37 | 2023 | 19873 | 0.800 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 396 | 0.800 |
Why?
|
| Pelvic Pain | 2 | 2018 | 9 | 0.750 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 104 | 0.740 |
Why?
|
| Private Sector | 1 | 2019 | 10 | 0.720 |
Why?
|
| Ki-67 Antigen | 1 | 2019 | 32 | 0.720 |
Why?
|
| Estrogen Receptor beta | 1 | 2019 | 37 | 0.710 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 78 | 0.690 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 105 | 0.680 |
Why?
|
| Insurance, Health | 1 | 2019 | 120 | 0.660 |
Why?
|
| Medicaid | 1 | 2019 | 102 | 0.650 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 358 | 0.630 |
Why?
|
| Protein-Lysine 6-Oxidase | 2 | 2015 | 64 | 0.620 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 446 | 0.590 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 600 | 0.580 |
Why?
|
| Lysine | 2 | 2015 | 104 | 0.580 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2020 | 1534 | 0.570 |
Why?
|
| Depression | 2 | 2021 | 664 | 0.540 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 198 | 0.540 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 1300 | 0.540 |
Why?
|
| Uterine Contraction | 1 | 2014 | 6 | 0.510 |
Why?
|
| Adult | 15 | 2020 | 11034 | 0.510 |
Why?
|
| Progesterone | 2 | 2015 | 117 | 0.500 |
Why?
|
| Cell Line | 5 | 2018 | 1289 | 0.480 |
Why?
|
| Congresses as Topic | 1 | 2014 | 38 | 0.480 |
Why?
|
| Biological Specimen Banks | 1 | 2014 | 21 | 0.480 |
Why?
|
| Humans | 27 | 2023 | 34853 | 0.480 |
Why?
|
| Puerto Rico | 8 | 2020 | 1352 | 0.480 |
Why?
|
| Tissue Array Analysis | 4 | 2019 | 65 | 0.480 |
Why?
|
| Anxiety | 3 | 2021 | 705 | 0.460 |
Why?
|
| Estradiol | 2 | 2015 | 244 | 0.450 |
Why?
|
| Gastrointestinal Motility | 2 | 2014 | 18 | 0.450 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2019 | 298 | 0.440 |
Why?
|
| Histone Deacetylase 2 | 1 | 2012 | 3 | 0.430 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 14 | 0.430 |
Why?
|
| Epithelial Cells | 1 | 2015 | 366 | 0.420 |
Why?
|
| Complement C3 | 1 | 2011 | 15 | 0.410 |
Why?
|
| Efficiency | 1 | 2011 | 17 | 0.410 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2011 | 33 | 0.410 |
Why?
|
| Cell Proliferation | 4 | 2018 | 1149 | 0.400 |
Why?
|
| Neoplasms | 3 | 2020 | 1033 | 0.400 |
Why?
|
| Health Status Indicators | 1 | 2011 | 73 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 638 | 0.390 |
Why?
|
| Rats | 12 | 2020 | 3261 | 0.390 |
Why?
|
| Work | 1 | 2010 | 6 | 0.380 |
Why?
|
| Uterine Diseases | 1 | 2010 | 5 | 0.380 |
Why?
|
| Health | 1 | 2010 | 28 | 0.370 |
Why?
|
| Gene Expression | 3 | 2012 | 639 | 0.370 |
Why?
|
| Indazoles | 2 | 2020 | 9 | 0.360 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1056 | 0.360 |
Why?
|
| Cell Movement | 3 | 2018 | 545 | 0.360 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 531 | 0.350 |
Why?
|
| Health Surveys | 1 | 2011 | 358 | 0.350 |
Why?
|
| Biomedical Research | 1 | 2014 | 371 | 0.350 |
Why?
|
| Pyridones | 2 | 2020 | 40 | 0.350 |
Why?
|
| Young Adult | 7 | 2020 | 4012 | 0.340 |
Why?
|
| Endometritis | 1 | 2007 | 2 | 0.320 |
Why?
|
| Animals | 18 | 2023 | 14307 | 0.320 |
Why?
|
| Lactobacillus | 1 | 2007 | 15 | 0.320 |
Why?
|
| Reproductive History | 1 | 2007 | 18 | 0.320 |
Why?
|
| Middle Aged | 9 | 2020 | 9642 | 0.310 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 34 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 430 | 0.300 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 4 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2005 | 21 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 12 | 0.270 |
Why?
|
| Polymorphism, Genetic | 2 | 2020 | 165 | 0.270 |
Why?
|
| Lymphocytes | 1 | 2006 | 116 | 0.270 |
Why?
|
| Cross-Sectional Studies | 4 | 2019 | 2561 | 0.270 |
Why?
|
| Adolescent | 4 | 2018 | 5035 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2017 | 304 | 0.240 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2023 | 14 | 0.230 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2023 | 17 | 0.230 |
Why?
|
| Mites | 1 | 2003 | 8 | 0.230 |
Why?
|
| Trypsin | 1 | 2003 | 39 | 0.230 |
Why?
|
| Uterus | 3 | 2020 | 54 | 0.230 |
Why?
|
| DNA, Complementary | 1 | 2003 | 175 | 0.220 |
Why?
|
| Cytokines | 1 | 2006 | 569 | 0.220 |
Why?
|
| Allergens | 1 | 2003 | 58 | 0.220 |
Why?
|
| Dust | 1 | 2003 | 51 | 0.220 |
Why?
|
| Inflammation | 2 | 2020 | 577 | 0.210 |
Why?
|
| Colitis | 3 | 2007 | 64 | 0.210 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2018 | 25 | 0.210 |
Why?
|
| Alleles | 2 | 2020 | 284 | 0.200 |
Why?
|
| Blotting, Western | 2 | 2015 | 834 | 0.190 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2020 | 3 | 0.190 |
Why?
|
| Skin Pigmentation | 1 | 2020 | 18 | 0.190 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 36 | 0.190 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 49 | 0.180 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 59 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 303 | 0.180 |
Why?
|
| Hysterectomy | 1 | 2019 | 29 | 0.180 |
Why?
|
| Laparoscopy | 1 | 2019 | 54 | 0.170 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 120 | 0.170 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2018 | 1 | 0.170 |
Why?
|
| Pyrroles | 1 | 2018 | 54 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 151 | 0.160 |
Why?
|
| Benzylamines | 1 | 2018 | 6 | 0.160 |
Why?
|
| Vitamin D | 1 | 2020 | 176 | 0.160 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 32 | 0.160 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2017 | 6 | 0.160 |
Why?
|
| Housing, Animal | 1 | 2017 | 11 | 0.160 |
Why?
|
| Receptor, trkA | 1 | 2017 | 7 | 0.160 |
Why?
|
| Colon | 3 | 2014 | 98 | 0.160 |
Why?
|
| Pyrimidines | 1 | 2018 | 112 | 0.160 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 21 | 0.160 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 25 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 188 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 176 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2019 | 351 | 0.150 |
Why?
|
| Neurogenesis | 1 | 2017 | 55 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 136 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 32 | 0.150 |
Why?
|
| Environment | 1 | 2017 | 130 | 0.150 |
Why?
|
| Macrophages | 1 | 2020 | 431 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2017 | 137 | 0.140 |
Why?
|
| Periaqueductal Gray | 1 | 2016 | 9 | 0.140 |
Why?
|
| Receptors, Opioid, mu | 1 | 2016 | 47 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 131 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2012 | 45 | 0.130 |
Why?
|
| Response Elements | 1 | 2015 | 52 | 0.130 |
Why?
|
| Methylation | 1 | 2015 | 102 | 0.130 |
Why?
|
| Defecation | 1 | 2014 | 5 | 0.130 |
Why?
|
| Biopsy | 1 | 2015 | 151 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 26 | 0.130 |
Why?
|
| Gene Frequency | 2 | 2012 | 155 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 160 | 0.120 |
Why?
|
| Corticosterone | 1 | 2014 | 73 | 0.120 |
Why?
|
| Maze Learning | 1 | 2014 | 100 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.120 |
Why?
|
| Transfection | 1 | 2015 | 496 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 162 | 0.120 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 394 | 0.120 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 26 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 325 | 0.120 |
Why?
|
| Acetylation | 1 | 2013 | 94 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2019 | 1961 | 0.120 |
Why?
|
| Minority Health | 1 | 2013 | 81 | 0.120 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 3 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2012 | 32 | 0.110 |
Why?
|
| Hormones | 1 | 2012 | 51 | 0.110 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 25 | 0.100 |
Why?
|
| ras Proteins | 1 | 2012 | 49 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 528 | 0.100 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 58 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 41 | 0.100 |
Why?
|
| Disease Progression | 3 | 2018 | 580 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 213 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 129 | 0.100 |
Why?
|
| Health Records, Personal | 1 | 2010 | 5 | 0.100 |
Why?
|
| Leukocyte Count | 2 | 2012 | 74 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 1426 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 32 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 229 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2010 | 79 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 517 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 1681 | 0.090 |
Why?
|
| United States | 1 | 2019 | 3894 | 0.090 |
Why?
|
| Women's Health | 1 | 2010 | 135 | 0.090 |
Why?
|
| Self Concept | 1 | 2010 | 136 | 0.090 |
Why?
|
| E-Selectin | 2 | 2005 | 19 | 0.090 |
Why?
|
| Phenotype | 1 | 2011 | 650 | 0.080 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 16 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 53 | 0.080 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 33 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2011 | 727 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 66 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 157 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2013 | 583 | 0.080 |
Why?
|
| Peroxidase | 1 | 2007 | 50 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2007 | 63 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 165 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 549 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 386 | 0.070 |
Why?
|
| Binding Sites | 2 | 2012 | 597 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2015 | 1802 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 1353 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2005 | 3 | 0.070 |
Why?
|
| Peritoneum | 1 | 2005 | 8 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 16 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 32 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 19 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 31 | 0.070 |
Why?
|
| Solubility | 1 | 2005 | 115 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2017 | 47 | 0.070 |
Why?
|
| Mitochondria | 1 | 2008 | 454 | 0.060 |
Why?
|
| Aging | 1 | 2008 | 639 | 0.060 |
Why?
|
| Syntenins | 1 | 2023 | 1 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 420 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2023 | 73 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 58 | 0.060 |
Why?
|
| Risk Factors | 1 | 2011 | 3414 | 0.060 |
Why?
|
| Prevalence | 1 | 2007 | 1425 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2008 | 874 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 249 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 310 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 416 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1124 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1490 | 0.040 |
Why?
|
| CA-125 Antigen | 1 | 2018 | 9 | 0.040 |
Why?
|
| Galectins | 1 | 2018 | 27 | 0.040 |
Why?
|
| Urocortins | 1 | 2017 | 4 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2017 | 13 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 281 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 707 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 5668 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 31 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 964 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 841 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 6448 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 2128 | 0.040 |
Why?
|
| Enkephalin, Methionine | 1 | 2016 | 7 | 0.040 |
Why?
|
| Enkephalin, Leucine | 1 | 2016 | 5 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2006 | 20 | 0.040 |
Why?
|
| beta-Endorphin | 1 | 2016 | 14 | 0.040 |
Why?
|
| Apoptosis | 1 | 2023 | 1317 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 338 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 878 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1349 | 0.030 |
Why?
|
| Male | 3 | 2020 | 18870 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 48 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2013 | 35 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2875 | 0.030 |
Why?
|
| Community Networks | 1 | 2013 | 98 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2013 | 159 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 2012 | 7 | 0.030 |
Why?
|
| Swimming | 1 | 2012 | 37 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 143 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 44 | 0.030 |
Why?
|
| Mast Cells | 1 | 2012 | 77 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2333 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 641 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 546 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 202 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 1023 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 1503 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 4 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2005 | 24 | 0.020 |
Why?
|
| Acute Disease | 1 | 2005 | 141 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 605 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1152 | 0.010 |
Why?
|